IN2013MU01117A - - Google Patents

Info

Publication number
IN2013MU01117A
IN2013MU01117A IN1117MU2013A IN2013MU01117A IN 2013MU01117 A IN2013MU01117 A IN 2013MU01117A IN 1117MU2013 A IN1117MU2013 A IN 1117MU2013A IN 2013MU01117 A IN2013MU01117 A IN 2013MU01117A
Authority
IN
India
Prior art keywords
preparation
present
relates
propanoate
pyridinyl
Prior art date
Application number
Other languages
English (en)
Inventor
Laxmikant Narhari Patkar
Harish Kashinath Mondkar
Nitin Dnyaneshwar Arote
Sachin Shivaji Patil
Original Assignee
Usv Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Ltd filed Critical Usv Ltd
Priority to IN1117MU2013 priority Critical patent/IN2013MU01117A/en
Priority to US14/779,911 priority patent/US9688657B2/en
Priority to PCT/IN2014/000188 priority patent/WO2014167577A2/en
Priority to CA2907839A priority patent/CA2907839C/en
Priority to EP14736463.2A priority patent/EP2978750B1/en
Priority to PL14736463T priority patent/PL2978750T3/pl
Priority to ES14736463T priority patent/ES2791187T3/es
Publication of IN2013MU01117A publication Critical patent/IN2013MU01117A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1117MU2013 2013-03-25 2014-03-25 IN2013MU01117A (enEXAMPLES)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN1117MU2013 IN2013MU01117A (enEXAMPLES) 2013-03-25 2014-03-25
US14/779,911 US9688657B2 (en) 2013-03-25 2014-03-25 Synthesis of dabigatran
PCT/IN2014/000188 WO2014167577A2 (en) 2013-03-25 2014-03-25 "synthesis of dabigatran"
CA2907839A CA2907839C (en) 2013-03-25 2014-03-25 Synthesis of dabigatran
EP14736463.2A EP2978750B1 (en) 2013-03-25 2014-03-25 "synthesis of dabigatran"
PL14736463T PL2978750T3 (pl) 2013-03-25 2014-03-25 Synteza Dabigatranu
ES14736463T ES2791187T3 (es) 2013-03-25 2014-03-25 Síntesis de dabigatrán

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1117MU2013 IN2013MU01117A (enEXAMPLES) 2013-03-25 2014-03-25

Publications (1)

Publication Number Publication Date
IN2013MU01117A true IN2013MU01117A (enEXAMPLES) 2015-05-01

Family

ID=54395366

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1117MU2013 IN2013MU01117A (enEXAMPLES) 2013-03-25 2014-03-25

Country Status (1)

Country Link
IN (1) IN2013MU01117A (enEXAMPLES)

Similar Documents

Publication Publication Date Title
SA515360469B1 (ar) مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها
PH12015502091A1 (en) Cdc7 inhibitors
IL225900A0 (en) A process for the preparation of nicotine that includes the enzymatic reduction of 4-(methylamino)-1-(3-pyridinyl)-1-butanone
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
AP2015008601A0 (en) Substituted 2-aza-bicyclo[2.2.1] heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
CO2017004784A2 (es) Isómeros de ácido-1-[(3-cloro-2-fluoro-fenil)metil]-4-[[3-fluoro-6-[(5-metil-1h-pirazol-3-il)amino]-2-piridil]metil]-2-metil-piperidin-4-carboxílico como inhibidores de la cinasa aurora a
IN2013MU00646A (enEXAMPLES)
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
IN2013CH05441A (enEXAMPLES)
MX2020011668A (es) Antagonistas duales de receptores de neurocinina-1 (nk-1)/neurocinina-3 (nk-3) para el tratamiento de enfermedades dependientes de hormonas sexuales.
MX376029B (es) Compuestos de isoindol.
PH12016500525A1 (en) Substituted phenylalanine derivatives
WO2014167577A3 (en) "synthesis of dabigatran"
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
NZ730816A (en) Quinoline carboxamides for use in the treatment of multiple myeloma
IN2015DN02616A (enEXAMPLES)
IN2014MU00675A (enEXAMPLES)
WO2014068587A3 (en) An improved process for the synthesis of dabigatran and its intermediates
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
IN2013MU01111A (enEXAMPLES)
MX2015017881A (es) Método para el tratamiento y/o prevención contra encefalopatía traumática crónica grado ii.
IN2015DN02601A (enEXAMPLES)
GEP201706614B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
IN2013MU01117A (enEXAMPLES)